Tags |
|
|
Casual Articles - Alzheimer's Disease
A free prepaid debit card is a viable alternative to a credit card. If you are looking for a mode of payment which can save money and also help you manage your finances, then you can go for free prepaid debit cards. Prepaid debit cards are easier to apply compared to credit cards. If you are an employee of a business organization, you are given a free prepaid debit card. You often get these cards free as a promotional move also.Free prepaid debit cards require no employee verification, bank accounts or past record of credit history. There is no credit line attached, so there is no worry about going past the credit limit and getting involved in a bad credit situation. You can manage your finances well and your overspending habits are curbed. Here are some of the 5 tips which can help you choose a free prepaid debit card wisely:1. World wide acceptability: Most free prepaid debit cards are accepted at locations and shopping outlets which display the logo of the debit card company. However there may be some places and shops where which your free prepaid debit card may not be accepted. Make sure that you thoroughly know about the acceptability of the card in most of the locations you will be shopping or using the card.2. Convenience: A prepaid debit card is just as convenient to use as a credit card. You should however know if you can use the card for online shopping and purchasing items over the phone. You can read the fine print of the free prepaid debit card company or find information from its website about the terms and conditions if any, of the usage of card online and for transactions over the phone.3. Value added services: Your free prepaid debit card company should give you different value added services like sending your statements online or through the mail to your home or office. Some prepaid debit cards also notify you about the salary credited to your account, on your cell phone itself. C
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March
For the past 15 years or so, I’ve been writing books and articles on the process I’ve developed that gives sellers the skills to teach buyers how to manage their systemic buying process. The good and bad news is that the field of sales is just now realizing that the buyers process is actually an important element of the sales process.It remains problematic, however, when sellers continue directing their focus toward product sale rather than decision facilitation and use what they think is knowledge about the buyer’s buying patterns as a manipulation into the selling end of the equation.It doesn’t work. Selling and buying are two separate, disparate, activities.Let’s say you know how a buyer buys – which is impossible for an outsider and difficult for an insider, given personalities, politics, communication, roles/rules, etc. But for arguments sake, let’s say you know exactly all of the internal, unique, systemic elements that to into the buyer’s unique, internal system and corresponding set of decisions. What are you going to do with that information? How would you sell into that?If you know, say, that the CEO makes all decisions, are you going to go over the head of your contact to try to persuade the CEO? Or spend months attempting to get in to see the CEO, only to be told once you’re there that s/he takes direction from a department head? I had a neighbor who was on the Board of a Fortune 50 company. He attempted to get me training work in the company. Didn’t work: the department heads (who met with me out of courtesy) told me they liked the way they were selling and didn’t want to change.What if it’s a committee? Are you going to call each person – even the ones you haven’t been introduced to – and take a ‘few moments’ of their time? And then what?What if it’s a small business, a Mom and Pop, and you know that the spouse needs to be involved? Are you going to wait for a time when y
AD is named after German doctor Alois Alzheimer. Dr. Alzheimer noticed changes in the brain tissue of a woman that died of an unusual mental illness. He found abnormal clumps (now called amyloid plaques) and tangled bundles of fibers (now called neurofibrillary tangles). Today, these plaques and tangles in the brain are considered hallmarks of AD. Many scientists have found other brain changes in people with AD. There is a loss of nerve cells in areas of the brain that are vital to memory and other mental abilities. There also are lower levels of chemicals in the brain that carry complex messages back and forth between nerve cells. AD may disrupt normal thinking and memory by blocking these messages between nerve cells.
Scientists are finding specific biologic factors involved with the AD. Different environmental and genetic aspects take part in causing AD. However, the actual cause of the disease is still unknown. The greatest known risk factors for late-onset Alzheimer’s are increasing age and a family history of AD. Researches all over the world are trying to find other factors that can cause AD.
AD is nowadays the fourth leading cause of death among the adults. Nearly four million Americans have it. The number doubles every five years in people over sixty five years old. By the age of eighty five almost half of Americans have AD. Some studies show that women have much higher risk of being affected by the AD than men (most of these studies were conducted on European and Asian populations, the U.S. studies, however, found no major differences). If there is a gender difference, then it is because of estrogen which is the main female’s hormone that is responsible for protecting against memory losses and normal mental functioning as compared to normal age. When a female gets older, the drop of estrogen level takes place after menopause and that could explain the higher risk of AD for older women than for men. From the other side, some of testosterone, male hormone, converts into estrogen and that could protect men. People that have a family history of the disease are above the average risk level for AD. Researchers have found that ApoE4 gene could be responsible for late and early onset cases. Some studies discovered that African Americans and Hispanics are at higher risk than Caucasian Americans, AD happens less often in Native Americans Crees and Cherokees and in Asians than in regular American population. Genes may have dissimilar effects in different populations.
High blood pressure and high cholesterol levels can be in fact even more risky than ApoE4. At a very high risk are also people that inherit the Down syndrome. Some other risk factors are: 1) lower education and economic groups, 2) small head size, 3) Depression, 4) head injury. A very dangerous thing about AD is that brain is being damaged for years before even the symptoms appear. The early symptoms that appear might be so mild that people could hardly notice them. The first one could be forgetfulness. People with AD may have troubles with recalling names of people that they know or remember latest events or solve simple math problems. As the disease progresses people may face
• Unreasonable weight losses
• Incontinence
• Changes in sexuality
• Difficulties in walking
• Depression, apathy, irritability
Half of all patients that have AD face the psychotic problems that can include hallucinations, visions. It is a complex form of the disease that is probably based in the genetic level. Many other medical conditions have similar to Alzheimer’s symptoms. It is crucially important to identify the right disease to succeed in future treatments of it. However, we have not yet developed a test that would diagnose AD with the hundred percent guarantee. So, right now diagnosis involves ruling out other disorders the following questions about the state of a patient:
• Do psychologist tests indicate dementia?
• Does the patient have problems with using language, walking, perception?
• Has memory gotten greatly worse?
• Is the patient over 40?
• Does his/her behavior changes daily?
• Does the patient have a family history of AD?
• Are there other symptoms like depression, weight loss, hallucinations?
Other steps that are involved in making a decision involve laboratory tests (EEG and tests to rule out other diseases) and psychological testing to determine the presence of dementia.
There is no guarantee that some life styles will prevent AD, however, studies show that particular life styles can play very important role in preventing AD. It is crucial to prevent heart diseases. Calcium – Channel Blocker and other Anti – Hypertensive Agents can be used to protect the heart and consequently the brain. Statins which are the common drugs to lower the cholesterol level can also be used to lower the risk for AD. Another method that is used to prevent AD is the Hormone Replacement Therapy. Because of the difference in AD rates among different populations, researches are looking at dietary factors as a protection. In China and Nigeria where fat consumption is much lower than in the U.S. the risk for AD at the age of sixty five is only 1% compared to 5% in the U.S. Studies in Netherlands reported the relationship between dementia and cholesterol levels. Eating a lot of dark colored fruits and vegetables may slow the brain degradation.
Blueberries are found to be the most helpful. In any case dark colored fruits and vegetables are good for health. Other studies showed that soy has estrogen which is thought to protect the memory. Some reported that small consumption of alcohol can be effective in stopping the brain aging. Not everybody agrees though. Caffeine has a good effect on women in terms of mental functioning. Much research on AD has showed that oxidation may have an impact in the disease process. Vitamin E may protect from mental decline. Other health behaviors like aerobic exercises or jogging are important in stopping the mental decline. The more person exercise the better. Another aspects that play role in the prevention of mental decline is lifelong learning and stress reduction.
Unfortunately, today we can only try to prevent AD and have no cures. However, there are drugs under investigation that are aimed to slow the progression of the AD. The bad thing is that improvements from some of these drugs can so little that a patient or his/her family would not even notice. The good thing is that even these drugs will help to postpone the necessity of taking a patient to a nursing home. The only agents that are approved called selective Acetylcholinesterase inhibitors. They are designed to protect the cholinergic system which is responsible for memory and learning and is destroyed in AD. We have the following:
• Donepezil. Donepezil (Aricept) is taken once a day and has only modest benefits but it helps to slow loss of function and reduce caregiver burden. It works equally in patients with or without ApoE4. It may even have some advantage for patients with moderate to severe Alzheimer's disease.
• Rivastigmine. Rivastigmine (Exelon) targets two enzymes (the major one, acetylcholinesterase, and butyrylcholinesterase). It is taken twice a day. This agent may be particularly beneficial for patients with rapidly progressing disease. This drug has slowed or slightly improved disease status even in patients with advanced disease. (Rivastigmine may cause significantly more side effects than donepezil, including nausea, vomiting, and headache.) As with all anticholinergics, the drug is not a cure.
• Galantamine (Reminyl). Galantamine not only protects the cholinergic system but also acts on nicotine receptors, which are also depleted during Alzheimer's Studies report that it improves daily living, behavior, and mental functioning, including in patients with mild to advanced-moderate Alzheimer's disease and those with a mix of Alzheimer's disease and vascular dementia. Some studies have suggested that the effects of galantamine may persist for a year or longer and even strengthen over time. • Tacrine. Tacrine (Cognex) was the first cholinergic protective drug. It needs to be taken four times a day, has only modest benefits, and has no benefits for patients who carry the ApoE4 gene. In high doses, it can also injure the liver. In general, newer cholinergic protective drugs that do not pose as great a risk for the liver are now used for Alzheimer's.
Half of the patients that have mild to moderate disease show sight improvement. Latest studies, however, show little difference in effectiveness among them. All these drugs have gastrointestinal side effects, including nausea. Anyway, these drugs still have some effect. Some researchers found that some patient could have no reactions to one particular drug, in this case the drug should be switched and there is actually a chance that it will work. There are also some alternative treatments that are being studied right now. One of them is Gingko Biloba. It is a common herb that increases blood flow to the brain.
Its extract Egb 761 may slightly improve the memory of patients that have mild to moderate AD. Gingko Biloba has only minimal side effects. Turmeric also has properties that may protect from AD. Turmeric is a spice that has curcumin as one of its components which is thought to protect from AD. Studies have also found that melatonin, the natural hormone that has to do with sleep regulation, could break down beta amyloid, and it is able to pass through the blood – brain barrier. Studies reported that melatonin improves the sleep, and in some cases even slows the mental regression.
A number of other medical treatments are being investigated and show promise in early or late trials. Researches are focusing on agents that can prevent the build-up of beta amyloid, its toxic effects on nerve cells, or other mechanisms of the disease process. Among them are the following:
• N-methyl-D-aspartate (NMDA) blockers. NMDA blockers, such as memantine (Ebixa), bind to glutamate, an amino acid that excites nerves and, in excess, is a powerful nerve-cell killer. Memantine has shown some to be somewhat effective in improving symptoms and is being considered for approval in Europe and the US.
• Growth factors that stimulate nerve activity in the brain. Cerebrolysin (Cere) is an example of such drugs and is showing promise in clinical trials in improving mental function and other symptoms, with sustained effects even after the drug has been stopped. Leteprinim potassium (Neotrofin) activates genes that produce nerve-growth factor in the brain. Early human trials are suggesting that it may have positive effects on memory and behavior. Insulin and insulin growth factors may prevent beta amyloid accumulation.
• Antioxidants. Indole-3-propionic acid, or IPA (Oxigon), is a natural agent that may interfere with enzymes that contribute to the Alzheimer's disease process.
• Huperzine alpha, another acetylcholinesterase inhibitor, improved mental function, behavior, and mood in Alzheimer's disease patients in one Chinese study. Other research also suggests some benefits.
• Piracetam is a nerve protective agent called a nootropic. It has undergone a number of small studies, with few significant results. More research is needed to determine any benefits. • Researchers are investigating immunotherapies that include vaccines, which use molecules in beta amyloid as targets for the body's immune system, and antibodies that block proteins called CD40-CD40L, which are involved in amyloid deposition.
• Tetracyclines. Antibiotics known as tetracyclines, such as tetracycline itself, doxycycline, and minocycline, have anti-inflammatory properties that are now being investigated in a number of chronic inflammatory conditions (such as periodontal disease). They also may have activity against beta amyloid in the brain.
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March
CD inkjet printers use inkjet technology to provide fast, high-quality printing options to users. For a large number of printing applications on discs, CD inkjet printers are preferred by many people. The latest models of CD inkjet printers could cost you more than a thousand dollars, but their speed is much higher than the lower-cost models. On some of the auction sites, you may get one dirt cheap. But check the cost of the ink cartridges used by the printer, as well as its speed. For a non-commercial user, a secondhand CD inkjet printer could also do. But those who want to use it for commercial purposes should go for the latest models.There are big brand names as well as hundreds of smaller and lesser-known brands in this market. There are many models available. Each model has its own distinct features. One should choose a model which suits one's needs. Generally, the maintenance costs of CD inkjet printers are very low, but there are some models where you might have to replace expensive cartridges too frequently.CD ink jet printers can print in black and white as well as in full color. The same CD printer can do both jobs. Of late, the focus of CD inkjet printers has been to improve the alignment as well as printing resolution, while reducing the time that ink takes to dry. A good CD inkjet printer can make the discs look very attractive, with various combinations of color, graphics, texts and photos.
High blood pressure and high cholesterol levels can be in fact even more risky than ApoE4. At a very high risk are also people that inherit the Down syndrome. Some other risk factors are: 1) lower education and economic groups, 2) small head size, 3) Depression, 4) head injury. A very dangerous thing about AD is that brain is being damaged for years before even the symptoms appear. The early symptoms that appear might be so mild that people could hardly notice them. The first one could be forgetfulness. People with AD may have troubles with recalling names of people that they know or remember latest events or solve simple math problems. As the disease progresses people may face
• Unreasonable weight losses
• Incontinence
• Changes in sexuality
• Difficulties in walking
• Depression, apathy, irritability
Half of all patients that have AD face the psychotic problems that can include hallucinations, visions. It is a complex form of the disease that is probably based in the genetic level. Many other medical conditions have similar to Alzheimer’s symptoms. It is crucially important to identify the right disease to succeed in future treatments of it. However, we have not yet developed a test that would diagnose AD with the hundred percent guarantee. So, right now diagnosis involves ruling out other disorders the following questions about the state of a patient:
• Do psychologist tests indicate dementia?
• Does the patient have problems with using language, walking, perception?
• Has memory gotten greatly worse?
• Is the patient over 40?
• Does his/her behavior changes daily?
• Does the patient have a family history of AD?
• Are there other symptoms like depression, weight loss, hallucinations?
Other steps that are involved in making a decision involve laboratory tests (EEG and tests to rule out other diseases) and psychological testing to determine the presence of dementia.
There is no guarantee that some life styles will prevent AD, however, studies show that particular life styles can play very important role in preventing AD. It is crucial to prevent heart diseases. Calcium – Channel Blocker and other Anti – Hypertensive Agents can be used to protect the heart and consequently the brain. Statins which are the common drugs to lower the cholesterol level can also be used to lower the risk for AD. Another method that is used to prevent AD is the Hormone Replacement Therapy. Because of the difference in AD rates among different populations, researches are looking at dietary factors as a protection. In China and Nigeria where fat consumption is much lower than in the U.S. the risk for AD at the age of sixty five is only 1% compared to 5% in the U.S. Studies in Netherlands reported the relationship between dementia and cholesterol levels. Eating a lot of dark colored fruits and vegetables may slow the brain degradation.
Blueberries are found to be the most helpful. In any case dark colored fruits and vegetables are good for health. Other studies showed that soy has estrogen which is thought to protect the memory. Some reported that small consumption of alcohol can be effective in stopping the brain aging. Not everybody agrees though. Caffeine has a good effect on women in terms of mental functioning. Much research on AD has showed that oxidation may have an impact in the disease process. Vitamin E may protect from mental decline. Other health behaviors like aerobic exercises or jogging are important in stopping the mental decline. The more person exercise the better. Another aspects that play role in the prevention of mental decline is lifelong learning and stress reduction.
Unfortunately, today we can only try to prevent AD and have no cures. However, there are drugs under investigation that are aimed to slow the progression of the AD. The bad thing is that improvements from some of these drugs can so little that a patient or his/her family would not even notice. The good thing is that even these drugs will help to postpone the necessity of taking a patient to a nursing home. The only agents that are approved called selective Acetylcholinesterase inhibitors. They are designed to protect the cholinergic system which is responsible for memory and learning and is destroyed in AD. We have the following:
• Donepezil. Donepezil (Aricept) is taken once a day and has only modest benefits but it helps to slow loss of function and reduce caregiver burden. It works equally in patients with or without ApoE4. It may even have some advantage for patients with moderate to severe Alzheimer's disease.
• Rivastigmine. Rivastigmine (Exelon) targets two enzymes (the major one, acetylcholinesterase, and butyrylcholinesterase). It is taken twice a day. This agent may be particularly beneficial for patients with rapidly progressing disease. This drug has slowed or slightly improved disease status even in patients with advanced disease. (Rivastigmine may cause significantly more side effects than donepezil, including nausea, vomiting, and headache.) As with all anticholinergics, the drug is not a cure.
• Galantamine (Reminyl). Galantamine not only protects the cholinergic system but also acts on nicotine receptors, which are also depleted during Alzheimer's Studies report that it improves daily living, behavior, and mental functioning, including in patients with mild to advanced-moderate Alzheimer's disease and those with a mix of Alzheimer's disease and vascular dementia. Some studies have suggested that the effects of galantamine may persist for a year or longer and even strengthen over time. • Tacrine. Tacrine (Cognex) was the first cholinergic protective drug. It needs to be taken four times a day, has only modest benefits, and has no benefits for patients who carry the ApoE4 gene. In high doses, it can also injure the liver. In general, newer cholinergic protective drugs that do not pose as great a risk for the liver are now used for Alzheimer's.
Half of the patients that have mild to moderate disease show sight improvement. Latest studies, however, show little difference in effectiveness among them. All these drugs have gastrointestinal side effects, including nausea. Anyway, these drugs still have some effect. Some researchers found that some patient could have no reactions to one particular drug, in this case the drug should be switched and there is actually a chance that it will work. There are also some alternative treatments that are being studied right now. One of them is Gingko Biloba. It is a common herb that increases blood flow to the brain.
Its extract Egb 761 may slightly improve the memory of patients that have mild to moderate AD. Gingko Biloba has only minimal side effects. Turmeric also has properties that may protect from AD. Turmeric is a spice that has curcumin as one of its components which is thought to protect from AD. Studies have also found that melatonin, the natural hormone that has to do with sleep regulation, could break down beta amyloid, and it is able to pass through the blood – brain barrier. Studies reported that melatonin improves the sleep, and in some cases even slows the mental regression.
A number of other medical treatments are being investigated and show promise in early or late trials. Researches are focusing on agents that can prevent the build-up of beta amyloid, its toxic effects on nerve cells, or other mechanisms of the disease process. Among them are the following:
• N-methyl-D-aspartate (NMDA) blockers. NMDA blockers, such as memantine (Ebixa), bind to glutamate, an amino acid that excites nerves and, in excess, is a powerful nerve-cell killer. Memantine has shown some to be somewhat effective in improving symptoms and is being considered for approval in Europe and the US.
• Growth factors that stimulate nerve activity in the brain. Cerebrolysin (Cere) is an example of such drugs and is showing promise in clinical trials in improving mental function and other symptoms, with sustained effects even after the drug has been stopped. Leteprinim potassium (Neotrofin) activates genes that produce nerve-growth factor in the brain. Early human trials are suggesting that it may have positive effects on memory and behavior. Insulin and insulin growth factors may prevent beta amyloid accumulation.
• Antioxidants. Indole-3-propionic acid, or IPA (Oxigon), is a natural agent that may interfere with enzymes that contribute to the Alzheimer's disease process.
• Huperzine alpha, another acetylcholinesterase inhibitor, improved mental function, behavior, and mood in Alzheimer's disease patients in one Chinese study. Other research also suggests some benefits.
• Piracetam is a nerve protective agent called a nootropic. It has undergone a number of small studies, with few significant results. More research is needed to determine any benefits. • Researchers are investigating immunotherapies that include vaccines, which use molecules in beta amyloid as targets for the body's immune system, and antibodies that block proteins called CD40-CD40L, which are involved in amyloid deposition.
• Tetracyclines. Antibiotics known as tetracyclines, such as tetracycline itself, doxycycline, and minocycline, have anti-inflammatory properties that are now being investigated in a number of chronic inflammatory conditions (such as periodontal disease). They also may have activity against beta amyloid in the brain.
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March
Well, I’d first like to talk about what exactly has inspired you to read this article. Was it just look that you’ve stumbled across it or was it because it was free or was it because you wanted a free and ultimately invaluable resource on starting your own Internet business. It doesn’t matter what you sell it could be anything from tennis shoes to e-books. Well really e-books is what I’m talking about.First of all, the e-book business is HARD, very hard. It’s competitive and you never know what exactly to do at the start. Below I am going to detail what you have to do, but remember that these are only guidelines and your imagination is welcome here!1) The most important thing I think you need to get first is a good product, without that you have nothing. It doesn’t have to be anything particularly spectacular, but you must be able to make it seem more than it really is. With e-books this is remarkably easy because all the sales letters come with the e-book when you purchase the e-book to resell. That means some poor person has had to write all that persuasive text for you for FREE!2) The next thing you need to get sorted is a web page of some sort, otherwise there’s no visual representation of what you have to give/sell to your visitors! A web page must be well laid out and be very easy to navigate. Your visitors must not struggle to pay for the product they want, if they struggle then the chances are they wont buy “If you can take a step out of the buying process do so!”3) After you have the ground made things sorted, you need to put yourself on the Internet this is covered in 3-4. The first thing you need to put your site on the Internet is a host of some sort. Most people use free hosts because they’re free; I disagree with this because they put banners/popups on your site, which do two things. They increase the page load time, making visitors wait longer. They also bamboozle the visitors and can
Unfortunately, today we can only try to prevent AD and have no cures. However, there are drugs under investigation that are aimed to slow the progression of the AD. The bad thing is that improvements from some of these drugs can so little that a patient or his/her family would not even notice. The good thing is that even these drugs will help to postpone the necessity of taking a patient to a nursing home. The only agents that are approved called selective Acetylcholinesterase inhibitors. They are designed to protect the cholinergic system which is responsible for memory and learning and is destroyed in AD. We have the following:
• Donepezil. Donepezil (Aricept) is taken once a day and has only modest benefits but it helps to slow loss of function and reduce caregiver burden. It works equally in patients with or without ApoE4. It may even have some advantage for patients with moderate to severe Alzheimer's disease.
• Rivastigmine. Rivastigmine (Exelon) targets two enzymes (the major one, acetylcholinesterase, and butyrylcholinesterase). It is taken twice a day. This agent may be particularly beneficial for patients with rapidly progressing disease. This drug has slowed or slightly improved disease status even in patients with advanced disease. (Rivastigmine may cause significantly more side effects than donepezil, including nausea, vomiting, and headache.) As with all anticholinergics, the drug is not a cure.
• Galantamine (Reminyl). Galantamine not only protects the cholinergic system but also acts on nicotine receptors, which are also depleted during Alzheimer's Studies report that it improves daily living, behavior, and mental functioning, including in patients with mild to advanced-moderate Alzheimer's disease and those with a mix of Alzheimer's disease and vascular dementia. Some studies have suggested that the effects of galantamine may persist for a year or longer and even strengthen over time. • Tacrine. Tacrine (Cognex) was the first cholinergic protective drug. It needs to be taken four times a day, has only modest benefits, and has no benefits for patients who carry the ApoE4 gene. In high doses, it can also injure the liver. In general, newer cholinergic protective drugs that do not pose as great a risk for the liver are now used for Alzheimer's.
Half of the patients that have mild to moderate disease show sight improvement. Latest studies, however, show little difference in effectiveness among them. All these drugs have gastrointestinal side effects, including nausea. Anyway, these drugs still have some effect. Some researchers found that some patient could have no reactions to one particular drug, in this case the drug should be switched and there is actually a chance that it will work. There are also some alternative treatments that are being studied right now. One of them is Gingko Biloba. It is a common herb that increases blood flow to the brain.
Its extract Egb 761 may slightly improve the memory of patients that have mild to moderate AD. Gingko Biloba has only minimal side effects. Turmeric also has properties that may protect from AD. Turmeric is a spice that has curcumin as one of its components which is thought to protect from AD. Studies have also found that melatonin, the natural hormone that has to do with sleep regulation, could break down beta amyloid, and it is able to pass through the blood – brain barrier. Studies reported that melatonin improves the sleep, and in some cases even slows the mental regression.
A number of other medical treatments are being investigated and show promise in early or late trials. Researches are focusing on agents that can prevent the build-up of beta amyloid, its toxic effects on nerve cells, or other mechanisms of the disease process. Among them are the following:
• N-methyl-D-aspartate (NMDA) blockers. NMDA blockers, such as memantine (Ebixa), bind to glutamate, an amino acid that excites nerves and, in excess, is a powerful nerve-cell killer. Memantine has shown some to be somewhat effective in improving symptoms and is being considered for approval in Europe and the US.
• Growth factors that stimulate nerve activity in the brain. Cerebrolysin (Cere) is an example of such drugs and is showing promise in clinical trials in improving mental function and other symptoms, with sustained effects even after the drug has been stopped. Leteprinim potassium (Neotrofin) activates genes that produce nerve-growth factor in the brain. Early human trials are suggesting that it may have positive effects on memory and behavior. Insulin and insulin growth factors may prevent beta amyloid accumulation.
• Antioxidants. Indole-3-propionic acid, or IPA (Oxigon), is a natural agent that may interfere with enzymes that contribute to the Alzheimer's disease process.
• Huperzine alpha, another acetylcholinesterase inhibitor, improved mental function, behavior, and mood in Alzheimer's disease patients in one Chinese study. Other research also suggests some benefits.
• Piracetam is a nerve protective agent called a nootropic. It has undergone a number of small studies, with few significant results. More research is needed to determine any benefits. • Researchers are investigating immunotherapies that include vaccines, which use molecules in beta amyloid as targets for the body's immune system, and antibodies that block proteins called CD40-CD40L, which are involved in amyloid deposition.
• Tetracyclines. Antibiotics known as tetracyclines, such as tetracycline itself, doxycycline, and minocycline, have anti-inflammatory properties that are now being investigated in a number of chronic inflammatory conditions (such as periodontal disease). They also may have activity against beta amyloid in the brain.
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March
The wave of revolution in the form of scintillating shopping malls, technological gizmos, swanky cars and many tempting commodities makes it difficult for us to resist the tendency to splurge. The more we look around us, the more we feel tempted to gratify our desires.Lifestyle has also transformed a lot in the past few years. Needs and desires have increased manifold. However, the income has not risen at the same rate as our needs. So, most of us face problems in fulfilling all our needs with the fixed monthly income.In order to cope up with the increased needs, sometimes borrowing money becomes inevitable. Previously, being debt free was considered to be a virtue. However, in today's scenario, borrowing money with an intelligent and judicious approach helps to enjoy life the way we want without burdening ourselves with debt. Easy personal loans are very popular among Britons as a means to fulfil their different needs in an easy and convenient manner. Many people are using these loans to purchase luxury items. The popularity of easy personal loans is due to the fact that there are no restrictions imposed by the lender on the usage of the loan money. A person can use the money for any purpose, such as purchasing a car, consolidating debts, funding higher education, paying off the pending medical bills, renovating home and so on.Personal loans may be in the form of secured or unsecured loans. People prefer unsecured personal loans when they are in need of urgent cash. Unsecured loans are granted without the need to put forth collateral. This reduces the paperwork involved in the loan approval process. As a result, a person gets the necessary money fast.Secured personal loans are usually taken for meeting expenses that involve a large amount of money. The loan is secured against a valuable asset, such as h
Its extract Egb 761 may slightly improve the memory of patients that have mild to moderate AD. Gingko Biloba has only minimal side effects. Turmeric also has properties that may protect from AD. Turmeric is a spice that has curcumin as one of its components which is thought to protect from AD. Studies have also found that melatonin, the natural hormone that has to do with sleep regulation, could break down beta amyloid, and it is able to pass through the blood – brain barrier. Studies reported that melatonin improves the sleep, and in some cases even slows the mental regression.
A number of other medical treatments are being investigated and show promise in early or late trials. Researches are focusing on agents that can prevent the build-up of beta amyloid, its toxic effects on nerve cells, or other mechanisms of the disease process. Among them are the following:
• N-methyl-D-aspartate (NMDA) blockers. NMDA blockers, such as memantine (Ebixa), bind to glutamate, an amino acid that excites nerves and, in excess, is a powerful nerve-cell killer. Memantine has shown some to be somewhat effective in improving symptoms and is being considered for approval in Europe and the US.
• Growth factors that stimulate nerve activity in the brain. Cerebrolysin (Cere) is an example of such drugs and is showing promise in clinical trials in improving mental function and other symptoms, with sustained effects even after the drug has been stopped. Leteprinim potassium (Neotrofin) activates genes that produce nerve-growth factor in the brain. Early human trials are suggesting that it may have positive effects on memory and behavior. Insulin and insulin growth factors may prevent beta amyloid accumulation.
• Antioxidants. Indole-3-propionic acid, or IPA (Oxigon), is a natural agent that may interfere with enzymes that contribute to the Alzheimer's disease process.
• Huperzine alpha, another acetylcholinesterase inhibitor, improved mental function, behavior, and mood in Alzheimer's disease patients in one Chinese study. Other research also suggests some benefits.
• Piracetam is a nerve protective agent called a nootropic. It has undergone a number of small studies, with few significant results. More research is needed to determine any benefits. • Researchers are investigating immunotherapies that include vaccines, which use molecules in beta amyloid as targets for the body's immune system, and antibodies that block proteins called CD40-CD40L, which are involved in amyloid deposition.
• Tetracyclines. Antibiotics known as tetracyclines, such as tetracycline itself, doxycycline, and minocycline, have anti-inflammatory properties that are now being investigated in a number of chronic inflammatory conditions (such as periodontal disease). They also may have activity against beta amyloid in the brain.
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March
Regardless of what profession you are in, you may want to make a career change to something better — particularly a dream job or unconventional business that you have thought about for some time. Remember that there is no such thing as a perfect job or business, however.There will always be barriers and adversity to overcome in any dream career or business. Even so — to the inspired and committed individuals of this world — leaving an old familiar job for something new is more adventure than adversity. New careers come with new problems but they come with new opportunities and wonderful experiences as well.Truth be known, to make a dramatic career change to that dream job you have to be a little crazy! Indeed, whatever new field you decide to enter in pursuit of real success without a real job, chances are someone is going to think that you are nuts.Relatives, acquaintances, friends, life coaches — even you — may doubt that you have what it takes to make it. The good news is that if others and you yourself think that you are at least a little bit crazy, this is a good sign that you can attain creative success in a new field of endeavor.Perhaps you are, in fact, a bit crazy. Not to worry — this is even a better sign!In his book, The Hypomanic Edge (Simon & Schuster, 2005), John Gartner establishes a link between craziness and success in America. Gartner, a psychologist at Johns Hopkins University, claims many of today’s successful entrepreneurs and business people exhibit hypomania, an energetic and ebullient state, which is a milder form of the mania associated with bipolar illness. Moreover, he contends that leading figures in American history, including Andrew Carnegie and Henry Ford, had the condition as well.While many successful entrepreneurs are not entirely crazy, they are not entirely normal, which leads others to believe they are crazy. Talk to America’s successful entr
The worst thing about Alzheimer’s disease is that it is not fully investigated yet. None of the doctors can surely diagnose it. And what is even worse none can cure it. The worst thing is that AD lethal in all case. Using all the treatments that have been or are still being studied can only postpone the need for the nursing home.
The issue of Alzheimer’s disease is crucially important to me and should be to everyone. Mainly, because nobody is insured from getting AD and there is no certain way to escape it. Our modern medicine has been developing through ages and now it cures many dangerous diseases; however, it is simply helpless against the Alzheimer’s. If scholars completely investigate AD it will help to understand the brain and its impact on people’s behavior. Using that knowledge it would be possible to impact the brain and its functions. Unfortunately, all the studies that were conducted about AD and were presented above can not state something about AD with a hundred percent certainty. All the medications that are listed above do not stop AD; they can even hardly slow it. It is very unpleasing fact that mankind has greatly developed ways to make the brain progress but have not yet found any way to stop the regression of the brain.
Bibliography
1. Rudolph E. Tanzi & Ann B. (2000). Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. Parson.
2. Mark L. Warner. (2000). The Complete Guide to Alzheimer's-Proofing Your Home. A.I.A.
3. Peter J., MD Whitehouse (Editor), Konrad, MD Maurer (Editor), Jesse F. Ballenger (Editor). (2000). Concepts of Alzheimer Disease: Biological, Clinical, and Cultural Perspectives. 4. Michael Castleman, Dolores Gallagher-Thompson, and Matthew Naythons. (2000). There's Still a Person in There: The Complete Guide to Treating and Coping with Alzheimer's. The Putnam Publishing Group.
5. Berkeley Heights. (2002). Alzheimer's Disease. Willett E. Enslow Publishers.
6. Terry RD, Katzman R, Bick KL, Sisodia SS (eds). (1999). Alzheimer Disease. Lippincott, Williams and Wilkins.
7. The American Journal of Alzheimer's Care and Related Disorders & Research, Reviewed By: Harvey Simon, Review Date: 3/31/2003. Retrieved March 23, 2005 from www.healthandage.com/html/well_connected/pdf/doc02.pdf
8. Alzheimer's Disease Education & Referral Center. General Information on AD. Retrieved March 23, 2005 from http://www.alzheimers.org/generalinfo.htm
9. Alzheimer’s Association. June 2, 2004. Fact Sheet. Retrieved March 23, 2005 from www.alz.org/Resources/FactSheets/FSADFacts.pdf
10. Alzheimer's Disease Education & Referral Center. Treatments of AD. Retrieved March 23, 2005 from http://www.alzheimers.org/treatment.htm
11. What is the Alzheimer’s Disease? Retrieved March 23, 2005 from www.alzheimersdisease.com/index.jsp - 72k
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.casualarticles.com/article/242146/casualarticles-Alzheimers-Disease.html">Alzheimer's Disease</a>
BB link (for phorums):
[url=http://www.casualarticles.com/article/242146/casualarticles-Alzheimers-Disease.html]Alzheimer's Disease[/url]
Related Articles:
Change And Confusion: Time To Refocus
All Prolific Online Article Authors Are Bad
Bookmark it:
|